Trial intelligence / Profile preview

Comparison of biphasic insulin aspart and insulin aspart on postprandial metabolism in type 2 diabetes

2008-008486-35Phase 4Completed

Sponsor
Medical University of Graz
Start
Feb 2010
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 4 trial of insulin aspart, biphasic insulin aspart and biphasic insulin aspart 70 in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Medical University of Graz. Primary endpoints: Postprandial glucose AUC first meal, Postprandial glucose AUC second meal and 1 more. Started Feb 2010; status: completed.

02

Drugs

insulin aspartbiphasic insulin aspartbiphasic insulin aspart 70
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2008-008486-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-008486-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call